BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of an immunoenzymatic method for determining the tumor marker CA 15-3)]. 1996

E Baghino, and G Dalmasso, and G Magrí
Laboratorio Analisi, USL n. 1-Presidio Ospedaliero, Imperia.

CA 15-3 determination has graved to be of clinical utility for diagnosis, evaluation and monitoring patients suffering from tumor. The aim of our study was to compare Sorin (kit ETI CA 15-3 K) and BMI (Enzymun-test CA 15.3) screening between two methodologies' capability. The results obtained were evaluated by using a Passing and Bablok correlation, Spearman rank correlation coefficient. The results obtained shown an over-valuation of the Sorin method vs. BMI.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D018396 Mucin-1 Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer. Antigen CA-15-3,CA-15-3 Antigen,Episialin,Epithelial Membrane Antigen,Epithelial Mucin, Polymorphic,Muc1 Mucin,Polymorphic Epithelial Mucin,Antigens, CD227,CA 15-3 Antigen,CA 15.3 Antigen,CD227 Antigen,Antigen CA 15 3,Antigen, CA 15-3,Antigen, CA 15.3,Antigen, CA-15-3,Antigen, CD227,Antigen, Epithelial Membrane,CA 15 3 Antigen,CA-15-3, Antigen,CD227 Antigens,Membrane Antigen, Epithelial,Mucin 1,Mucin, Muc1,Mucin, Polymorphic Epithelial

Related Publications

E Baghino, and G Dalmasso, and G Magrí
Tumor marker CA 15-3 in breast cancer patients.
January 2015, Acta medica academica,
E Baghino, and G Dalmasso, and G Magrí
[CA 15-3--a tumor marker in breast cancer].
December 1993, Harefuah,
E Baghino, and G Dalmasso, and G Magrí
[Evaluation of an immunoenzymatic method for determining TSH and establishment of reference values].
December 1992, Bollettino della Societa italiana di biologia sperimentale,
E Baghino, and G Dalmasso, and G Magrí
CA 15-3 as a tumor marker in gynecological malignancies.
June 1988, Gynecologic oncology,
E Baghino, and G Dalmasso, and G Magrí
Evaluation of CA 15-3 tumor marker in the diagnosis of breast cancer. A pilot study.
January 1994, Neoplasma,
E Baghino, and G Dalmasso, and G Magrí
[Clinical significance of the tumor marker CA 15-3 in mammary carcinoma].
November 1986, Rinsho byori. The Japanese journal of clinical pathology,
E Baghino, and G Dalmasso, and G Magrí
[Clinical significance of CA 15-3 assay as a tumor marker].
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
E Baghino, and G Dalmasso, and G Magrí
Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
March 2020, Acta biochimica Polonica,
E Baghino, and G Dalmasso, and G Magrí
[Evaluation of CA 15-3 radioimmunoassay].
January 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
E Baghino, and G Dalmasso, and G Magrí
[Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
October 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!